AtriCure, Inc. Proceeds from Long-Term Debt Issued
AtriCure, Inc. (ATRC) reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2026-02-19
- AtriCure, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-12-31 was $0.00.
- AtriCure, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-09-30 was $0.00.
- AtriCure, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-06-30 was $0.00.
- AtriCure, Inc. proceeds from issuance of long-term debt for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- AtriCure, Inc. proceeds from issuance of long-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- AtriCure, Inc. proceeds from issuance of long-term debt for fiscal 2024 was $61.21M.
- AtriCure, Inc. proceeds from issuance of long-term debt for fiscal 2023 was $0.00.
- AtriCure, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $0.00 10-Q · filed 2025-10-30 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $0.00 10-Q · filed 2025-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $61.21M 10-K · filed 2026-02-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $0.00 derived: sum of 2 quarters · filed 2025-10-30 | $61.21M 10-Q · filed 2025-10-30 | $61.21M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $61.21M 10-Q · filed 2025-07-30 | $61.21M derived: sum of 3 quarters · filed 2026-02-19 | $61.21M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $61.21M 10-Q · filed 2025-04-30 | $61.21M derived: sum of 2 quarters · filed 2026-02-19 | $61.21M derived: sum of 3 quarters · filed 2026-02-19 | $61.21M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $0.00 10-Q · filed 2024-07-31 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-14 | |||
| 2021-12-31 | $5.00M 10-K · filed 2024-02-16 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-22 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $20.00M 10-K · filed 2022-02-17 | ||
| 2019-09-30 | $20.00M 10-Q · filed 2019-10-31 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $0.00 derived: sum of 2 quarters · filed 2021-02-26 | $17.38M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $17.38M 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $17.38M 10-Q · filed 2019-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |